Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gamze Varan, Safiye Akkın, Nurbanu Demirtürk, Juan M. Benito & Erem Bilensoy. (2021) Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. Journal of Drug Targeting 29:4, pages 439-453.
Read now
Read now
Bingren Hu, Huajie Cai, Shouzhang Yang, Jinfu Tu, Xiaming Huang & Gang Chen. (2019) Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells. OncoTargets and Therapy 12, pages 11437-11451.
Read now
Read now
Articles from other publishers (4)
Cecilia C. Ayala-Aguilera, Teresa Valero, Álvaro Lorente-Macías, Daniel J. Baillache, Stephen Croke & Asier Unciti-Broceta. (2021) Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis. Journal of Medicinal Chemistry 65:2, pages 1047-1131.
Crossref
Crossref
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif & Ahmed M. Gouda. (2021) Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism. Molecules 26:21, pages 6677.
Crossref
Crossref
Michal Mahdal, Jakub Neradil, Peter Mudry, Silvia Paukovcekova, Iva Staniczkova Zambo, Jiri Urban, Peter Macsek, Lukas Pazourek, Tomas Tomas & Renata Veselska. (2021) New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling. Cancers 13:14, pages 3543.
Crossref
Crossref
Jennifer W. Harris, Tianyan Gao & B. Mark Evers. 2015. Intestinal Tumorigenesis. Intestinal Tumorigenesis
101
135
.